STAFF REPORTS
Two new grants from the National Institute of Neurological Disorders and Stroke (NINDS) will pave the way for new treatments for neuronal ceroid lipofuscinoses and Charcot Marie Tooth diseases, two groups of rare neurological disorders. The funding, which totals $10 million, will support new research programs led by University of Rochester Medical Center (URMC) neurologists Erika Augustine, M.D., and David Herrmann, M.B.B.Ch., and involve an international team of scientists and clinicians.
Originally published on https://urmc.rochester.edu/news/story.aspx?id=5555
All WNY is made possible thanks to coffee and sleep deprivation.
We appreciate your readership. We like money, too.